发明名称 MODIFIED ERYTHROPOIETIN TO WHICH WATER-SOLUBLE LONG-CHAIN MOLECULE IS ADDED
摘要 Disclosed is a pharmaceutical composition which contains erythropoietin as an active ingredient and exerts a hematopoietic effect that lasts for 7 days or more when administered to a human and/or an animal. Specifically disclosed are: a pharmaceutical composition that contains erythropoietin, to which two or more water-soluble long-chain molecules are added, in an amount of not less than 50% of the total erythropoietin; a pharmaceutical composition that contains erythropoietin to which a water-soluble long-chain molecule is added, said water-soluble long-chain molecule having a molecular weight of not less than 30 kDa; and a pharmaceutical composition that contains erythropoietin to which a water-soluble long-chain molecule is added, said water-soluble long-chain molecule having a branched chain.
申请公布号 CA2773596(A1) 申请公布日期 2011.03.24
申请号 CA20102773596 申请日期 2010.09.15
申请人 KANEKA CORPORATION 发明人 TANI, NOBUTAKA;FUJII, TOSHIHIDE;WATANABE, HIROYUKI;MAEDA, HIROFUMI
分类号 A61K38/22;A61K9/06;A61K9/08;A61K47/10;A61K47/18;A61K47/34;A61P7/06;A61P43/00 主分类号 A61K38/22
代理机构 代理人
主权项
地址